Announcements Trials

Browse Landscape

Status

Sponsor Class

Study Type

Observational 1

Sponsor

Cancer Type

Conditions

Breast Neoplasms 695 Neoplasms 613 Prostatic Neoplasms 315 Lung Neoplasms 308 Colorectal Neoplasms 282 Carcinoma, Non-Small-Cell Lung 254 Pancreatic Neoplasms 178 Carcinoma, Hepatocellular 168 Stomach Neoplasms 139 Multiple Myeloma 127 Ovarian Neoplasms 120 Melanoma 118 Colonic Neoplasms 112 Brain Neoplasms 108 Hematologic Neoplasms 107 Head and Neck Neoplasms 106 Urinary Bladder Neoplasms 103 Leukemia, Myeloid, Acute 102 Esophageal Neoplasms 101 Disease 100 Uterine Cervical Neoplasms 89 Neoplasm Metastasis 89 Liver Neoplasms 88 Rectal Neoplasms 85 Lymphoma 84 Precursor Cell Lymphoblastic Leukemia-Lymphoma 83 Endometrial Neoplasms 76 Carcinoma, Renal Cell 73 Leukemia 63 Recurrence 62

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Observational × Mast Cell Activation Disorders × 1 year × Clear all

NCT06186856 2026-04-22

DATAMAST

Imagine Institute

13,000 enrolled

Mast Cell Activation Disorders, Mastocytosis

Data powered by HemOnc (CC BY 4.0) Colophon ⚡